Skip to main content
Log in

Tuberkulose im Kindesalter

Pathogenese, Prävention, Klinik und Therapie

Tuberculosis in childhood

Pathogenesis, prevention, clinical situation and therapy

  • Published:
Monatsschrift Kinderheilkunde Aims and scope Submit manuscript

Zusammenfassung

Wenngleich die Tuberkulose im Kindesalter in Deutschland inzwischen eine seltene Infektionskrankheit geworden ist, werden die Kinderärzte auch in Zukunft, aufgrund von Bevölkerungsmigrationen aus Hochprävalenzländern, mit diesem Krankheitsbild konfrontiert sein. Gezielte Präventionsmaßnahmen sollen dazu beitragen, ein Wiederaufleben der TB in Deutschland zu vermeiden. Eine wichtige ärztliche Aufgabe besteht v. a. darin, die Tuberkulose weiterhin in die Differenzialdiagnostik einzubeziehen. So gilt es besonders, latente Infektionen mittels Infektionsanamnese, Tuberkulinhauttestung und ggf. neuen In-vitro-Testverfahren zu detektieren und bei Indikation zu behandeln. Manifeste Tuberkulosen müssen dem Standard entsprechend kombiniert therapiert werden. Eine Differenzierung von Umweltmykobakteriosen („nontuberculous mycobacteria“: NTM) und Tuberkulose, z. B. bei der zervikalen Lymphadenopathie, ist notwendig, da sich das therapeutische Vorgehen bei beiden Krankheiten wesentlich unterscheidet. Umweltmykobakteriosen scheinen bei Kindern hierzulande insgesamt zuzunehmen.

Abstract

In Germany, the incidence of childhood tuberculosis (Tb) continues to decline. Nevertheless, pediatricians are still be confronted with Tb due to migration from high incidence countries. Measures are needed to prevent the revival of Tb in Germany. This mainly involves the detection and treatment of latent Tb-infection by infection history, tuberculin-skin testing and, if necessary, interferon-gamma assays. The inclusion of Tb in the differential diagnosis of unclear lung disease is therefore important. Active disease has to be treated by combined chemotherapy as recommended. On the other hand, there seems to be an increase in infections with non-tuberculous mycobacteria (NTM). The therapy in NTM-infection differs from that in Tb, therefore differentiation between Tb and NTM-infections, for example in cervical lymphadenopathy, is important.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Algood HM, Lin PL, Flynn JL (2005) Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin Infect Dis [Suppl 3] 41:S189–S193

    Google Scholar 

  2. Alzeer AH, FitzGerald JM (1993) Corticosteroids and tuberculosis: risks and use as adjunct therapy. Tuber Lung Dis 74:6–11

    Article  PubMed  Google Scholar 

  3. American Thoracic Society, Centers for Disease Control and Prevention (2000) Targeted tuberculin testing, and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 161:S221–S247

    PubMed  Google Scholar 

  4. Bellamy R (2005) Genetic susceptibility to tuberculosis. Clin Chest Med 26:233–246

    Article  PubMed  Google Scholar 

  5. Brodie D, Schluger NW (2005) The diagnosis of tuberculosis. Clin Chest Med 26:247–271

    Article  PubMed  Google Scholar 

  6. Casanova J-L, Abel L (2004) The human model: a genetic dissection of immunity to infection in natural conditions. Nat Rev Immunol 4:55–66

    Article  PubMed  Google Scholar 

  7. Centers for Disease Control and Prevention (CDC) (2005) Human tuberculosis caused by Mycobacterium bovis — New York City, 2001–2004. MMWR Morb Mortal Wkly Rep 54:605–608

    PubMed  Google Scholar 

  8. Centers for Disease Control and Prevention (1992) Management of persons exposed to multidrug-resistant tuberculosis. MMWR Recomm Rep 41:61–71

    PubMed  Google Scholar 

  9. Chapman AL, Munkanta M, Wilkinson KA et al. (2002) Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 16:2285–2293

    Article  PubMed  Google Scholar 

  10. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (2001) Richtlinien zur medikamentösen Behandlung der Tuberkulose im Erwachsenen- und Kindesalter. Pneumologie 55:494–511

    Article  PubMed  Google Scholar 

  11. Dooley KE, Sterling TR (2005) Treatment of latent tuberculosis infection: challenges and prospects. Clin Chest Med 26:313–326

    Article  PubMed  Google Scholar 

  12. Feja K, Saiman L (2005) Tuberculosis in children. Clin Chest Med 26:295–312

    Article  PubMed  Google Scholar 

  13. Haimi-Cohen Y (2001) Skin indurations in response to tuberculin testing in patients with nontuberculous mycobacterial lymphadenitis. Clin Infect Dis 33:1786–1788

    Article  PubMed  Google Scholar 

  14. Hauer B, Mauch H, Loddenkemper R et al. (2005) Der Tuberkulose-Schnelltest von DiaVita — keine Alternative zum Tuberkulinhauttest. Pneumologie 59: 681–684

    Article  PubMed  Google Scholar 

  15. Haverkamp MH, Arend SM, Lindeboom JA et al. (2004) Nontuberculous mycobacterial infection in children: a 2-year prospective surveillance study in the Netherlands. Clin Infect Dis 39:450–456

    Article  PubMed  Google Scholar 

  16. Huebner RE, Schein MF, Bass JB Jr (1993) The tuberculin skin test. Clin Infect Dis 17:968–975

    PubMed  Google Scholar 

  17. Iseman MD (1993) Treatment of multidrug-resistant tuberculosis. N Engl J Med 329:784–791

    Article  PubMed  Google Scholar 

  18. Kauschke K, Magdorf K, Wahn U (1998) Mykobakteriell bedingte Lymphadenitis bei Kindern in Berlin 1981–1996. Monatsschr Kinderheilkd Suppl 2:S159

  19. Kumar R, Gupta N, Sabharwal AS (2005) Congenital tuberculosis. Indian J Pediatr 72:631–633

    PubMed  Google Scholar 

  20. Lalvani A, Pathan AA, McShane H et al. (2001) Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 163:824–828

    PubMed  Google Scholar 

  21. Lobato MN, Hopewell PC (2000) Mycobacterium tuberculosis infection after travel to or contact with visitors from countries with a high prevalence of tuberculosis. Am J Respir Crit Care Med 158:1871–1875

    Google Scholar 

  22. Loddenkemper R (2005) Aktuelle Information des DZK zur Tuberkulinversorgung Deutschlands. Pneumologie 59:236–237

    Article  PubMed  Google Scholar 

  23. Magdorf K, Arizzi-Rusche AF, Geiter LJ et al. (1994) Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood — a pilot project. Pneumologie 48:761–764

    PubMed  Google Scholar 

  24. Magdorf K (2003) Tuberkulose und nicht-tuberkulöse mykobakterielle Krankheiten. In: DGPI (Hrsg) Handbuch, Infektionen bei Kindern und Jugendlichen, 4. Aufl. Futuramed, München, S 699–719

  25. Magdorf K (2001) Prävention der Tuberkulose im Kindesalter. Monatsschr Kinderheilkd 149:713–716

    Article  Google Scholar 

  26. Magdorf K, Ertel M, Wahn U (1997) Tuberkulose im Kindesalter 2. Tuberkuloseformen, Symptomatik und Therapie. Pädiatr Prax 52:299–309

  27. Mandalakas AM, Starke JR (2005) Current concepts of childhood tuberculosis. Semin Pediatr Infect Dis 6:93–104

    Article  Google Scholar 

  28. Martin C (2005) The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG? Eur Respir J 26:162–167

    Article  PubMed  Google Scholar 

  29. Mori T, Sakatani M, Yamagishi F et al. (2004) Specific detection of tuberculosis infection an interferon γ–based assay using new antigens. Am J Respir Crit Care Med 170:59–64

    Article  PubMed  Google Scholar 

  30. Neutra MR, Mantis NJ, Kraehenbuhl JP (2001) Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol 2:1004–1009

    Article  PubMed  Google Scholar 

  31. O’Brien RJ, Spigelman M (2005) New drugs for tuberculosis: current status and future prospects. Clin Chest Med 26:327–340

    Article  PubMed  Google Scholar 

  32. Ormerod P (2001) Tuberculosis in pregnancy and the puerperium. Thorax 56:494–499

    Article  PubMed  Google Scholar 

  33. Ozuah PO, Ozuah TP, Stein REK et al. (2001) Evaluation of a risk assessment questionnaire used to target tuberculin skin testing in children. JAMA 285:451–453

    Article  PubMed  Google Scholar 

  34. Pai M, Riley LW, Colford JM Jr (2004) Interferongamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4:761–776

    Article  PubMed  Google Scholar 

  35. Ridzon R, Meador J, Maxwell R et al. (1997) Asymptomatic hepatitis in persons who received alternative preventive therapy with pyrazinamide and ofloxacin. Clin Infect Dis 24:1264–1265

    PubMed  Google Scholar 

  36. Robert-Koch-Institut (2005) Infektionsepidemiologisches Jahrbuch für 2004. Robert-Koch-Institut, Berlin, S 162–165

  37. Romanus V, Hallander H, Wahlen P et al. (1995) Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination. Tuber Lung Dis 76:300–310

    Article  PubMed  Google Scholar 

  38. Schoeman JF, Van Zyl LE, Laubscher JA et al. (1997) Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics 99:226–231

    Article  PubMed  Google Scholar 

  39. Sharma SK, Mohan A, Sharma A et al. (2005) Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis 5:415–430

    Article  PubMed  Google Scholar 

  40. Ständige Impfkommission am Robert-Koch-Institut (STIKO) (1998) Impfempfehlungen. Epidemiol Bull 15:109–112

    Google Scholar 

  41. Swaminathan S, Raghavan A, Duraipandian M et al. (2005) Short-course chemotherapy for paediatric respiratory tuberculosis: 5-year report. Int J Tuberc Lung Dis 9:693–696

    PubMed  Google Scholar 

  42. Ulrichs T, Kaufmann SHE (2003) Immunology and persistence. Issues Infect Dis 2:112–127

    Google Scholar 

  43. Verver S, Van Loenhout-Rooyackers JH, Bwire R et al. (2005) Tuberculosis infection in children who are contacts of immigrant tuberculosis patients. Eur Respir J 26:126–132

    Article  PubMed  Google Scholar 

  44. Wallgren A (1948) The time-table of tuberculosis. Tubercle 29:245–251

    Google Scholar 

  45. Wiese-Posselt M, Siedler A, Rademacher A et al. (2004) ESPID-study-group 2 incidence of nontuberculous mycobacteria (NTM) in children aged <15 years, Germany 2002–2004. ESPID Annual Meeting, Tampere, Finland, May 2004

  46. Zar HJ, Hanslo D, Apolles P (2005) Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet 365:130–134

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt:

Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Magdorf.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Magdorf, K. Tuberkulose im Kindesalter. Monatsschr Kinderheilkd 154, 124–132 (2006). https://doi.org/10.1007/s00112-005-1282-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00112-005-1282-3

Schlüsselwörter

Keywords

Navigation